Physician profile
Mark Schreck
NPI 1043630551
$13,018.28
in general payments reported to CMS, 2019-2025
8 companies · $74.08 in 2025
The $74.08 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,645 · 2021: $1,030 · 2023: $138 · 2025: $74.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,514.96 | 2019-2020 | |
| Prodigy Surgical Distribution, INC. | $1,092.28 | 2020 | |
| Skeletal Dynamics INC | $958.82 | 2020-2021 | |
| Endo Pharmaceuticals INC. | $248.29 | 2019-2023 | Xiaflex |
| Stryker Corporation | $143.69 | 2021-2025 | Variax |
| Endo USA, INC. | $22.64 | 2025 | Xiaflex |
| Integra Lifesciences Corporation | $20.91 | 2023 | Tenoglide |
| Baxter Healthcare | $16.69 | 2025 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Schreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.